首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe
【24h】

Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe

机译:实验医学准备好迎接个性化医学时代了吗?针对欧洲医院/医学院的实验室主任的调查

获取原文
获取原文并翻译 | 示例
           

摘要

Developments in "-omics" are creating a paradigm shift in laboratory medicine leading to personalized medicine. This allows the increase in diagnostics and therapeutics focused on individuals rather than populations. In order to investigate whether laboratory medicine is ready to play a key role in the integration of personalized medicine in routine health care and set the state-of-the-art -knowledge about personalized medicine and laboratory medicine in Europe, a questionnaire was constructed under the auspices of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the European Society of Pharmacogenomics and Personalised Therapy (ESPT). The answers of the participating laboratory medicine professionals indicate that they are aware that personalized medicine can represent a new and promising health model, and that laboratory medicine should play a key role in supporting the implementation of personalized medicine in the clinical setting. Participants think that the current organization of laboratory medicine needs additional/relevant implementations such as (i) new technological facilities in -omics; (ii) additional training for the current personnel focused on the new methodologies; (iii) incorporation in the laboratory of new competencies in data interpretation and counseling; and (iv) cooperation and collaboration among professionals of different disciplines to integrate information according to a personalized medicine approach.
机译:“-组学”的发展正在引起实验室医学向个体化医学的范式转变。这使得针对个人而非人群的诊断和治疗方法的增加。为了调查实验室医学是否准备好在个性化医学与常规卫生保健的整合中发挥关键作用,并建立欧洲关于个性化医学和实验室医学的最新知识,由欧洲临床化学和检验医学联合会(EFLM)和欧洲药物基因组学和个性化治疗学会(ESPT)主持。与会的实验室医学专业人士的回答表明,他们知道个性化医学可以代表一种新的有前途的健康模型,并且实验室医学应在支持个性化医学在临床环境中的实施中发挥关键作用。与会者认为,当前的实验室医学组织需要其他/相关的实施方式,例如:(i)组学中的新技术设施; (ii)对现有人员的额外培训集中在新方法上; (iii)在实验室中纳入新的数据解释和咨询能力; (iv)不同学科专业人士之间的合作与协作,以根据个性化医学方法整合信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号